Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Ophthalmology|February 10, 2026
Real-world efficacy of faricimab for diabetic macular edema: One year outcomes and evidence of undertreatmentGeorge Zelhof, Ticiana Criddle, Philip I Burgess
Cornea|April 25, 2008
SmartPlug versus silicone punctal plug therapy for dry eye: a prospective randomized trialPhilip I Burgess, Peter Koay, Patricia Clark
European Journal of Ophthalmology|March 10, 2010
Paraneoplastic exudative retinal detachment associated with adenocarcinoma of the lungPhilip I Burgess, Nihal Kenawy, Ian A Pearce
BMC Medicine|July 4, 2013
Diabetic retinopathy in sub-Saharan Africa: meeting the challenges of an emerging epidemicPhilip I Burgess, Gerald Msukwa, Nicholas A V Beare
Tropical Medicine & International Health : TM & IH|February 1, 2014
Posterior segment eye disease in sub-Saharan Africa: review of recent population-based studiesAndrew Bastawrous, Philip I Burgess, Abdull M Mahdi, et al.
Ophthalmology|July 14, 2016
First Prospective Cohort Study of Diabetic Retinopathy from Sub-Saharan Africa: High Incidence and Progression of Retinopathy and Relationship to Human Immunodeficiency Virus InfectionPhilip I Burgess, Simon P Harding, Marta García-Fiñana, et al.
Diabetes, Obesity & Metabolism|July 8, 2026
Early Worsening of Diabetic Retinopathy Following Initiation of Hybrid Closed-Loop/Automated Insulin Delivery Systems in Type 1 Diabetes: A Systematic Review and Structured Study-Level SynthesisMatthew Anson, Ahmed Iqbal, Shazli Azmi, et al.
The British Journal of Ophthalmology|April 26, 2011
Prevalence of diabetic retinopathy, cataract and visual impairment in patients with diabetes in sub-Saharan AfricaSimon J Glover, Philip I Burgess, Danielle B Cohen, et al.
Plos One|August 3, 2017
Incidence and progression of diabetic retinopathy in Sub-Saharan Africa: A five year cohort studyPhilip I Burgess, Simon P Harding, Marta García-Fiñana, et al.
Eye (London, England)|September 19, 2025
Cost-effectiveness of anti-vascular endothelial growth factor and macular laser treatments for people with centre-involving diabetic macular oedema and central retinal thickness of at least 400 micrometresKirsty Luckham, Hannah Tebbs, Clare Dadswell, et al.
Pageof 2